Clinical Trial Update: Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 study evaluating mitoxantrone and prednisone with or without leflunomide in stage IV prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ARAVA (leflunomide)
• Novantrone (mitoxantrone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Pfizer | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: COMPLETED